参考文献/References:
[1] ZHANG F,YAN Y,PENG W,et al.PARK7 promotes repair in early steroid-induced osteonecrosis of the femoral head by enhancing resistance to stress-induced apoptosis in bone marrow mesenchymal stem cells via regulation of the Nrf2 signaling pathway[J].Cell Death Dis,2021,12(10):940.
[2] WYLES C C,PARADISE C R,HOODEK M T,et al.Brand award disruption in peroxisome proliferator-activated receptor-γ(PPARG)increases osteonecrosis risk through genetic variance and pharmacologic modulation[J].Clin Orthop Relat Res,2019,477(8):1800-1812.
[3] ZHANG F,PENG W,WANG T,et al.Lnc Tmem235 promotes repair of early steroid-induced osteonecrosis of the femoral head by inhibiting hypoxia-induced apoptosis of BMSCs[J].Exp Mol Med,2022,54(11):1991-2006.
[4] MENG K,LIU Y,RUAN L,et al.Suppression of apoptosis in osteocytes,the potential way of natural medicine in the treatment of osteonecrosis of the femoral head[J].Biomed Pharmacother,2023,162:114403.
[5] DUAN P,WANG H,YI X,et al.C/EBPα regulates the fate of bone marrow mesenchymal stem cells and steroid-induced avascular necrosis of the femoral head by targeting the PPARγ signalling pathway[J].Stem Cell Res Ther,2022,13(1):342.
[6] LOZUPONE M,SOLFRIZZI V,SARDONE R,et al.The epigenetics of frailty[J].Epigenomics,2024,16(3):189-202.
[7] ZHANG W,BAI Y,HAO L,et al.One-carbon metabolism supports S-adenosylmethionine and m6A methylation to control the osteogenesis of bone marrow stem cells and bone formation[J].J Bone Miner Res,2024,39(9):1356-1370.
[8] FANG B,WANG D,ZHENG J,et al.Involvement of tumor necrosis factor alpha in steroid-associated osteonecrosis of the femoral head:friend or foe?[J].Stem Cell Res Ther,2019,10(1):5.
[9] MILLER C A,SWEATT J D.Covalent modification of DNA regulates memory formation[J].Neuron,2007,53(6):857-869.
[10] SUN Z,YANG S,YE S,et al.Aberrant CpG islands'hypermethylation of ABCB1 in mesenchymal stem cells of patients with steroid-associated osteonecrosis[J].J Rheumatol,2013,40(11):1913-1920.
[11] CHEN T H,WEBER F E,MALINA-ALTZINGER J,et al.Epigenetic drugs as new therapy for tumor necrosis factor-α-compromised bone healing[J].Bone,2019,127:49-58.
[12] WU F,JIAO J,LIU F,et al.Hypermethylation of Frizzled1 is associated with Wnt/β-catenin signaling inactivation in mesenchymal stem cells of patients with steroid-associated osteonecrosis[J].Exp Mol Med,2019,51(2):1-9.
[13] HU L,LU J,CHENG J,et al.Structural insight into substrate preference for TET-mediated oxidation[J].Nature,2015,527(7576):118-122.
[14] ZHAO J,MA X L,MA J X,et al.TET3 mediates alterations in the epigenetic marker 5hmC and Akt pathway in steroid-associated osteonecrosis[J].J Bone Miner Res,2017,32(2):319-332.
[15] ZHU D,ZHANG Y,WANG S.Histone citrullination:a new target for tumors[J].Mol Cancer,2021,20(1):90.
[16] BLACK J C,VAN RECHEM C,WHETSTINE J R.Histone lysine methylation dynamics:establishment,regulation,and biological impact[J].Mol Cell,2012,48(4):491-507.
[17] JIANG W,AGRAWAL D K,BOOSANI C S.Cell-specific histone modifications in atherosclerosis[J].Mol Med Rep,2018,18(2):1215-1224.
[18] SCHWARZ D,VARUM S,ZEMKE M,et al.Ezh2 is required for neural crest-derived cartilage and bone forma-tion[J].Development,2014,141(4):867-877.
[19] ZHANG F,LUO H,PENG W,et al.Hypoxic condition induced H3K27me3 modification of the lncRNA Tmem235 promoter thus supporting apoptosis of BMSCs[J].Apoptosis,2022,27(9):762-777.
[20] 隋昊,张陶.组蛋白去甲基化酶在间充质干细胞成骨和成软骨分化中的作用综述[J].四川大学学报(医学版),2021,52(3):364-372.
[21] GHORBANINEJAD M,KHADMI-SHIRVAN M,HOSSEINI S,et al.Epidrugs:novel epigenetic regulators that open a new window for targeting osteoblast differentiation[J].Stem Cell Res Thery,2020,11:456.
[22] 陈达.基于组蛋白去甲基化酶JMJD家族探讨血瘀型激素性股骨头坏死的发病机制[D].广州:广州中医药大学,2016.
[23] LI N,DHAR S S,CHEN T Y,et al.JARID1D is a suppressor and prognostic marker of prostate cancer invasion and metastasis[J].Cancer Research,2016,76(4):831-843.
[24] 黄林峰.基于RNA-seq技术对肾虚血瘀型股骨头坏死差异基因筛选及生物信息学分析[D].广州:广州中医药大学,2021.
[25] WANG F S,LIAN W S,LEE M S,et al.Histone demethylase UTX counteracts glucocorticoid deregulation of osteogenesis by modulating histone-dependent and -independent pathways[J].J Mol Med(Berl),2017,95(5):499-512.
[26] WANG B,GONG S,HAN L,et al.Knockdown of HDAC9 inhibits osteogenic differentiation of human bone marrow mesenchymal stem cells partially by suppressing the MAPK signaling pathway[J].Clin Interv Aging,2022,17:777-787.
[27] 王博.下调的HDAC9通过抑制骨髓间充质干细胞成骨偶联成血管分化促进激素性股骨头坏死的发生[D].武汉:华中科技大学,2019.
[28] 李明.股骨头坏死相关基因的相关性、多态性及保护性研究[D].济南:山东大学,2018.
[29] MISHRA A,KUMAR R,MISHRA S N,et al.Differential expression of non-coding RNAs in stem cell development and therapeutics of bone disorders[J].Cells,2023,12(8):1159.
[30] KTENA Y P,DIONYSIOU M,GONDEK L P,et al.The impact of epigenetic modifications on allogeneic hematopoietic stem cell transplantation[J].Front Immunol,2023,14:1188853.
[31] KLIPP A,BURGER M,LEROUX J C.Get out or die trying:peptide-and protein-based endosomal escape of RNA therapeutics[J].Adv Drug Deliv Rev,2023,200:115047.
[32] LI D,LIU L,HE X,et al.Roles of long non-coding RNAs in angiogenesis-related diseases:focusing on non-neoplastic aspects[J].Life Sci,2023,330:122006.
[33] CHAO H,HU Y,ZHAO L,et al.Biogenesis,functions,interactions,and resources of non-coding RNAs in plants[J].Int J Mol Sci,2022,23(7):3695.
[34] SWEEF O,ZAABOUT E,BAKHEET A,et al.Unraveling therapeutic opportunities and the diagnostic potential of microRNAs for human lung cancer[J].Pharmaceutics,2023,15(8):2061.
[35] CORNEC A,POIRIER E Z.Interplay between RNA interference and transposable elements in mammals[J].Front Immunol,2023,14:1212086.
[36] CUI Y,HUANG T,ZHANG Z,et al.The potential effect of BMSCs with miR-27a in improving steroid-induced osteonecrosis of the femoral head[J].Sci Rep,2022,12(1):21051.
[37] SUN J,WANG Y,LI Y,et al.Downregulation of PPARγ by miR-548d-5p suppresses the adipogenic differentiation of human bone marrow mesenchymal stem cells and enhances their osteogenic potential[J].J Transl Med,2014,12:168.
[38] HAO C,YANG S,XU W,et al.MiR-708 promotes steroid-induced osteonecrosis of femoral head,suppresses osteo-genic differentiation by targeting SMAD3[J].Sci Rep,2016,6:22599.
[39] ZUO R,KONG L,WANG M,et al.Exosomes derived from human CD34+ stem cells transfected with miR-26a prevent glucocorticoid-induced osteonecrosis of the femoral head by promoting angiogenesis and osteogenesis[J].Stem Cell Res Ther,2019,10(1):321.
[40] ZHANG S,XIA Y,CHEN W,et al.Regulation and therapeutic application of long non-coding RNA in tumor angiogenesis[J].Technol Cancer Res Treat,2024,23:15330338241273239.
[41] SAKSHI S,JAYASURIYA R,GANESAN K,et al.Role of circRNA-miRNA-mRNA interaction network in diabetes and its associated complications[J].Mol Ther Nucleic Acids,2021,26:1291-1302.
[42] XU Y,JIANG Y,WANG Y,et al.LINC00473-modified bone marrow mesenchymal stem cells incorporated thermosensitive PLGA hydrogel transplantation for steroid-induced osteonecrosis of femoral head:a detailed mechanistic study and validity evaluation[J].Bioeng Transl Med,2021,7(2):e10275.
[43] HAO Y,LU C,ZHANG B,et al.CircPVT1 up-regulation attenuates steroid-induced osteonecrosis of the femoral head through regulating miR-21-5p-mediated Smad7/TGFβ signalling pathway[J].J Cell Mol Med,2021,25(10):4608-4622.
[44] 赫龙,高爽,李志刚,等.基于三大组学探讨从“痰、虚、瘀”论治SANFH的可行性[J].时珍国医国药,2022,33(8):1947-1949.
[45] SUN Z B,WANG J W,XIAO H,et al.Icariin may benefit the mesenchymal stem cells of patients with steroid-associated osteonecrosis by ABCB1-promoter demethylation:a preliminary study[J].Osteoporos Int,2015,26(1):187-197.
[46] ZHANG C,YUAN S,CHEN Y,et al.Neohesperidin promotes the osteogenic differentiation of human bone marrow stromal cells by inhibiting the histone modifications of lncRNA SNHG1[J].Cell Cycle,2021,20(19):1953-1966.
[47] CHEN L,WANG B Z,XIE J,et al.Therapeutic effect of SIRT3 on glucocorticoid-induced osteonecrosis of the femoral head via intracellular oxidative suppression[J].Free Radic Biol Med,2021,176:228-240.
中医正骨2025年6月第37卷第6期 J Trad Chin Orthop Trauma,2025,Vol.37,No.6(总445)
(总446)中医正骨2025年6月第37卷第6期 J Trad Chin Orthop Trauma,2025,Vol.37,No.6
[48] ZHANG S Y,WANG F,ZENG X J,et al.Astragalus polysaccharide ameliorates steroid-induced osteonecrosis of femoral head through miR-206/HIF-1α/BNIP3 axis[J].Kaohsiung J Med Sci,2021,37(12):1089-1100.
[49] 武瑞臣,崔书伟,李双庆.牛膝甾酮抑制miR-98-5p促进激素性股骨头坏死大鼠BMSC自噬及成骨分化[J].中医学报,2023,38(6):1139-1145.
[50] 阎博昭.补肾活血胶囊通过VASH1-AS1/let-7d-5p/SLC5A6轴调控成骨成血管防治激素性股骨头坏死的作用机制研究[D].济南:山东中医药大学,2023.
[51] YANG F,ZHANG X,SONG T,et al.Huogu injection alleviates SONFH by regulating adipogenic differentiation of BMSCs via targeting the miR-34c-5p/MDM4 pathway[J].Gene,2022,838:146705.
[52] 马学强.生骨再造丸通过FKBP52/GRα/miRNA-708信号通路对激素性股骨头坏死BMSCs成脂分化的影响[D].兰州:甘肃中医药大学,2022.
[53] 王多贤.生骨再造丸对FKBP52/GRα/miRNA-708信号通路及激素性股骨头坏死兔BMSCs成骨分化的影响[D].兰州:甘肃中医药大学,2022.
[54] 李小冬,刘旭卓,任天琦,等.活骨灌注液对激素诱导的骨髓间充质干细胞成骨分化及Sirt1/LC3基因表达的影响[J].辽宁中医药大学学报,2022,24(6):29-33.
相似文献/References:
[1]陈雷雷,张颖.何伟教授采用中医药疗法治疗股骨头坏死的经验[J].中医正骨,2015,27(10):74.
[2]徐西林,赵永兰,张晓峰,等.活骨注射液髋关节腔灌注对兔股骨头坏死模型
血管内皮生长因子表达的动态影响[J].中医正骨,2015,27(08):1.
XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(06):1.
[3]周勇,任菲菲,丰凡翔,等.血管内皮生长因子和骨形态发生蛋白2
在非创伤性股骨头坏死不同区域的表达[J].中医正骨,2015,27(08):7.
ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(06):7.
[4]鲍荣华,王国平,夏晓斌,等.钽棒植入治疗非创伤性股骨头坏死的疗效观察[J].中医正骨,2015,27(02):28.
[5]张兵,马凰富,刘波,等.非创伤性股骨头坏死的舌象定量研究[J].中医正骨,2015,27(04):8.
ZHANG Bing,MA Huangfu,LIU Bo,et al.Quantitative study on tongue manifestation of patients with nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(06):8.
[6]李刚,程春生.股骨头坏死血瘀证症状与平乐郭氏正骨方药药物组成
最大频繁关联模式挖掘[J].中医正骨,2015,27(04):21.
LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(06):21.
[7]李文龙,梅沉成,杜贵强,等.微创减压植骨多孔钽棒植入治疗
ARCOⅡ期非创伤性缺血性股骨头坏死[J].中医正骨,2016,28(02):43.
[8]张磊,金红婷,童培建.骨健口服液早期干预非创伤性股骨头坏死的临床研究[J].中医正骨,2016,28(03):14.
ZHANG Lei,JIN Hongting,TONG Peijian.Clinical study on Gujian Koufuye(骨健口服液)for early intervention of nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(06):14.
[9]鲍荣华,王国平,夏晓斌,等.直接前入路微创全髋关节置换术治疗晚期股骨头坏死[J].中医正骨,2016,28(03):61.
[10]张超,姚晨,沈计荣.微创髓芯减压打压支撑植骨术结合补肾活血汤口服治疗ARCOⅡ、Ⅲ期股骨头坏死的近期疗效观察[J].中医正骨,2016,28(03):20.
ZHANG Chao,YAO Chen,SHEN Jirong.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(06):20.
[11]周占国,郭浩山,关涛,等.股骨头坏死病因的相关因素分析[J].中医正骨,2020,32(01):7.
[12]杨琪,杜炯,孙继高,等.股骨头坏死中医证型分析[J].中医正骨,2020,32(01):14.
[13]许珂,宇文星,宋梦歌,等.股骨头坏死全髋关节置换术患者的人群特征与临床特点分析[J].中医正骨,2020,32(01):51.
[14]李向洲,邢涛,张应拴,等.中药治疗激素性股骨头坏死作用机制的研究进展[J].中医正骨,2023,35(02):33.
[15]杨博,邢涛,张应拴,等.从伏邪理论论治激素性股骨头坏死[J].中医正骨,2023,35(02):54.
[16]方伟华,庄至坤,彭鹏,等.激素性股骨头坏死滑膜病变分子机制的实验研究[J].中医正骨,2024,36(09):49.
FANG Weihua,ZHUANG Zhikun,PENG Peng,et al.Molecular mechanisms of synovial lesions in steroid-induced osteonecrosis of the femoral head:an experimental study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2024,36(06):49.
[17]田佳庆,刘良燕,彭鹏,等.基于“成骨-成血管”理论探讨全身振动疗法治疗激素性股骨头坏死的效果及作用机制[J].中医正骨,2024,36(09):59.
TIAN Jiaqing,LIU Liangyan,PENG Peng,et al.Efficacy and mechanism of whole body vibration therapy in treatment of steroid-induced osteonecrosis of the femoral head:a osteogenesis-angiogenesis theory-based experimental study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2024,36(06):59.
[18]彭鹏,肖欢,方伟华,等.激素性股骨头坏死囊性变组织骨修复机制分析与活血通络胶囊含药血清对肥大软骨细胞成骨分化影响的实验研究[J].中医正骨,2024,36(09):19.
PENG Peng,XIAO Huan,FANG Weihua,et al.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2024,36(06):19.